Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Raises Target Price to $8

Moomoo News13:31 ET · Ratings

Analysts Are Bullish on Top Healthcare Stocks: BioRestorative Therapies (BRTX), Rocket Pharmaceuticals (RCKT)

TipRanks13:00 ET · Ratings

BioRestorative Announces FDA Clearance Of IND for Phase 2 Trial Of BRTX-100 In Chronic Cervical Discogenic Pain

BenzingaFeb 27 09:47 ET

Express News | BioRestorative Announces Updated Time for February 27TH Webcasted Conference Call to Discuss Clinical Pipeline Update

ReutersFeb 26 20:15 ET

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

GlobeNewswireFeb 25 08:00 ET

BioRestorative Receives FDA Fast Track Designation For BRTX-100 Program For Chronic Lumbar Disc Disease

BenzingaFeb 20 08:31 ET

Express News | BioRestorative Receives FDA Fast Track Designation for Brtx-100 Chronic Lumbar Disc Disease Program

ReutersFeb 20 08:30 ET

Maxim Group Initiates Biorestorative Therapies(BRTX.US) With Buy Rating, Announces Target Price $8

Moomoo NewsFeb 12 16:31 ET · Ratings

Promising Phase 2 Results and Market Dynamics Boost Confidence in BioRestorative Therapies

TipRanksFeb 12 15:45 ET

BioRestorative Therapies Issues Regulation FD Disclosure

TipRanksFeb 10 12:44 ET

BioRestorative Therapies Announces New Data on BRTX-100 Presented at ORS 2025

TipRanksFeb 10 07:21 ET

Express News | BioRestorative Therapies, Inc. Highlights Presentation Or Preliminary BRTX-100 Data At Orthopaedic Research Society

BenzingaFeb 10 07:11 ET

BRTX-100 Front and Center at ORS 2025

GlobeNewswireFeb 10 07:00 ET

BioRestorative Therapies, Inc.'s (NASDAQ:BRTX) Shift From Loss To Profit

Yahoo FinanceFeb 5 05:33 ET

Pleasing Signs As A Number Of Insiders Buy BioRestorative Therapies Stock

Yahoo FinanceDec 26, 2024 06:26 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 5, 2024 16:05 ET

Express News | BioRestorative Therapies Inc - Patent Protection Expected Until April 29, 2040

ReutersDec 5, 2024 06:45 ET

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem Metabolic Disease Program

GlobeNewswireDec 5, 2024 06:45 ET

Express News | BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting Thermostem® Metabolic Disease Program

ReutersDec 5, 2024 06:45 ET

Maxim Group Maintains Biorestorative Therapies(BRTX.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 14, 2024 14:32 ET · Ratings